http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113292510-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D275-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D275-04 |
| filingDate | 2021-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113292510-B |
| titleOfInvention | Benzisothiazole compounds inhibiting the activity of hypoxia-inducible factor 2, preparation method and application thereof |
| abstract | The invention discloses a benzisothiazole compound for inhibiting the activity of hypoxia-inducible factor 2, a preparation method and an application. Oxygen inducible factor 2 transcriptional activity, thereby inhibiting the oncogene downstream of hypoxia inducible factor 2, effectively inhibiting the proliferation of cancer cell lines, has potential anti-tumor activity, has anti-tumor medicinal uses, and can be used to prepare anti-tumor drugs. |
| priorityDate | 2021-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 176.